Cash Flow Mochida Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
8,052.00
6,160.00
9,044.00
14,591.00
11,900.00
6,273.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-1,319.00
-15,140.00
-131.00
-4,317.00
-3,684.00
-602.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
9,354.00
-7,480.00
7,297.00
7,459.00
9,198.00
9,347.00
Cash Flow from Investing Activities
17,355.00
74.00
-2,949.00
-2,007.00
-880.00
-1,760.00
Cash Flow from Financing Activities
-2,865.00
-6,393.00
-6,884.00
-5,956.00
-5,112.00
-5,328.00
Net Cash Inflow / Outflow
23,860.00
-13,720.00
-2,504.00
-473.00
3,197.00
2,259.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
16.00
79.00
32.00
31.00
-9.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Mochida Pharmaceutical Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
8052
26330
-18,278.00
-69.42%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-1319
-10530
9,211.00
87.47%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
9354
23401
-14,047.00
-60.03%
Cash Flow from Investing Activities
17355
-31287
48,642.00
155.47%
Cash Flow from Financing Activities
-2865
21567
-24,432.00
-113.28%
Net Cash Inflow / Outflow
23860
15597
8,263.00
52.98%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
16
1916
-1,900.00
-99.16%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 225.05% vs -202.51% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
9,354.00
-7,480.00
225.05%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
